摘要
Introduction: Ischemic stroke occurs when blood flow to the brain is blocked, resulting in neurological impairment and brain tissue injury. Despite promising preclinical findings, 94% of Phase III neuroprotection trials have reported no positive results. Most preclinical stroke studies use genetically identical C57BL/6 mice. However, these mice do not reflect the genetic diversity of human populations and thus may offer limited translational value in human clinical settings. HET3 mice, derived from four inbred strains (BALB/cByJ, C57BL/6J, C3H/HeJ and DBA/2J), comprise greater genetic diversity. This study aims to characterise the chronic effects of ischaemic stroke in HET3 mice and compare outcomes with C57BL/6 mice.
Methods: Male and female C57BL/6 and HET3 mice aged 10–16 weeks were subjected to photothrombotic stroke in the left primary motor cortex. Functional outcomes were assessed over an 8-week period using the cylinder test to measure forelimb asymmetry. At the experimental endpoint brains were collected, brain infarct and atrophy were delineated. Immunohistochemistry was performed to assess astrogliosis and glial scar formation.
Results: HET3 mice showed greater functional impairment at 1 and 8 weeks after photothrombotic stroke compared with C57BL/6 mice. At 8 weeks post-stroke, infarct volume was not different between the strains. However, C57BL/6 mice showed greater brain atrophy than HET3 mice. No strain differences were observed in astrogliosis or glial scar formation.
Conclusion: Our findings suggest that HET3 mice are a suitable model for studying chronic ischemic stroke. As they comprise a more genetically diverse platform for investigating mechanisms underlying long-term post-stroke impairment, data obtained from this mice strain could be more relevant for clinical translation.
